Preoperative mFOLFIRINOX (or Gem-Nab-P) +/- Isotoxic High-dose SBRT for Borderline Resectable Pancreatic Adenocarcinoma

NCT05083247 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

256

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Neoplasm
Pancreatic Adenocarcinoma
Borderline Resectable Pancreatic Adenocarcinoma

Interventions

DRUG: mFOLFIRINOX or Gemcitabine nab-paclitaxel
RADIATION: Isotoxic High-Dose (iHD)-SBRT
PROCEDURE: Surgery

Sponsor

Erasme University Hospital

Collaborators

[object Object]
[object Object]
[object Object]